Advancements, challenges and future perspectives on peptide-based drugs: Focus on antimicrobial peptides

被引:56
|
作者
Luo, Xiaofang [1 ,2 ]
Chen, Huifang [1 ,2 ]
Song, Yannan [1 ,2 ]
Qin, Zuodong [1 ,2 ]
Xu, Lijian [1 ]
He, Nongyue [1 ]
Tan, Yimin [1 ]
Dessie, Wubliker [2 ]
机构
[1] Hunan Univ Technol, Hunan Key Lab Biomed Nanomat & Devices, Zhuzhou 412007, Peoples R China
[2] Hunan Univ Sci & Engn, Coll Chem & Bioengn, Hunan Engn Technol Res Ctr Comprehens Dev & Utiliz, Yongzhou 425199, Peoples R China
关键词
Peptide drugs; Antimicrobial peptides; Antibiotics; Drug resistance; Oral delivery; Bioavailability; MOLECULAR-DYNAMICS SIMULATIONS; HOST-DEFENSE PEPTIDE; IN-VITRO; DELIVERY; THERAPEUTICS; PHARMACOKINETICS; FORMULATION; MECHANISMS; BACTERIA; ANTIBACTERIAL;
D O I
10.1016/j.ejps.2022.106363
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Among other health related issues, the rising concerns on drug resistance led to look for alternative pharmaceutical drugs that are effective both against infectious and noninfectious diseases. Antimicrobial peptides (AMPs) emerged as potential therapeutic molecule with wide range of applications. With their limitations, AMPs have gained reputable attentions in research as well as in the pharmaceutical industry. This review highlighted the historical background, research trends, technological advancements, challenges, and future perspectives in the development and applications of peptide drugs. Some vital questions related with the need for pharmaceutical production, factors for the slow and steady journey, the importance of oral bioavailability, and the drug resistance possibilities of AMPs were raised and addressed accordingly. Therefore, the current study is believed to provide a profound understanding in the past and current scenarios and future directions on the therapeutic impacts of peptide drugs.
引用
收藏
页数:15
相关论文
共 50 条
  • [41] Applications of antimicrobial peptides from fish and perspectives for the future
    Rajanbabu, Venugopal
    Chen, Jyh-Yih
    PEPTIDES, 2011, 32 (02) : 415 - 420
  • [42] UCB: Strong future for peptide-based therapies
    Scott, A
    CHEMICAL WEEK, 2002, 164 (48) : 27 - 27
  • [43] Advances in the delivery and application of antimicrobial peptide-based nanomaterials
    Deng, Haoran
    Zhang, Shaohua
    Fu, Yanxue
    Dong, Na
    Bi, Chongpeng
    Shan, Anshan
    Shao, Changxuan
    CHEMICAL ENGINEERING JOURNAL, 2024, 496
  • [44] Engineering Approaches for the Development of Antimicrobial Peptide-Based Antibiotics
    Kang, Su-Jin
    Nam, So Hee
    Lee, Bong-Jin
    ANTIBIOTICS-BASEL, 2022, 11 (10):
  • [45] Strategies to improve the physicochemical properties of peptide-based drugs
    Michelle Felicia Lee
    Chit Laa Poh
    Pharmaceutical Research, 2023, 40 : 617 - 632
  • [46] Strategies to improve the physicochemical properties of peptide-based drugs
    Lee, Michelle Felicia
    Poh, Chit Laa
    PHARMACEUTICAL RESEARCH, 2023, 40 (03) : 617 - 632
  • [47] The Century-Long Journey of Peptide-Based Drugs
    Almeida, Jose R.
    ANTIBIOTICS-BASEL, 2024, 13 (03):
  • [48] Advancements, challenges, and future frontiers in covalent inhibitors and covalent drugs: A review
    Hameed, Muhammad Salman
    Cao, Hongxuan
    Guo, Li
    Zeng, Lei
    Ren, Yanliang
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY REPORTS, 2024, 12
  • [49] Wafer-Scale Computing: Advancements, Challenges, and Future Perspectives [Feature]
    Hu, Yang
    Lin, Xinhan
    Wang, Huizheng
    He, Zhen
    Yu, Xingmao
    Zhang, Jiahao
    Yang, Qize
    Xu, Zheng
    Guan, Sihan
    Fang, Jiahao
    Shang, Haoran
    Tang, Xinru
    Dai, Xu
    Wei, Shaojun
    Yin, Shouyi
    IEEE CIRCUITS AND SYSTEMS MAGAZINE, 2024, 24 (01) : 52 - 81
  • [50] The future challenges facing the development of new antimicrobial drugs
    Anthony Coates
    Yanmin Hu
    Richard Bax
    Clive Page
    Nature Reviews Drug Discovery, 2002, 1 : 895 - 910